What Was the Ice Bucket Challenge For? ALS Explained

The Ice Bucket Challenge was a viral fundraising campaign for ALS, a fatal neurodegenerative disease also known as Lou Gehrig’s disease. During the summer of 2014, millions of people filmed themselves dumping buckets of ice water over their heads, donated money, and nominated friends to do the same within 24 hours. The campaign raised over $115 million for the ALS Association in just eight weeks and became one of the most successful fundraising events in history.

How ALS Affects the Body

ALS, or amyotrophic lateral sclerosis, destroys the motor neurons that carry signals from the brain to the muscles. As those neurons deteriorate and die, muscles stop receiving instructions and gradually lose function. It often starts with subtle signs: weakness in a hand or foot, slurred speech, trouble swallowing. Over time, the disease spreads to the muscles that control movement, breathing, and eating.

The prognosis is brutal. Half of people diagnosed with ALS die within 14 to 18 months, though some live 10 years or longer. Before 2014, the disease received relatively little public attention or research funding compared to other conditions, which is exactly what the Ice Bucket Challenge set out to change.

How the Challenge Started

The challenge didn’t begin with a celebrity or a marketing firm. It started with a family connection. Professional golfer Chris Kennedy is believed to be the first person to pour ice water over his head specifically in the name of ALS. He challenged his cousin, Jeanette Senerchia, whose husband Anthony was living with the disease. Jeanette filmed herself taking the challenge, posted it online, and nominated three friends.

From there, it reached Pat Quinn, who had been diagnosed with ALS, and then Pete Frates, a former college baseball player diagnosed at age 27 in 2012. Pat and Pete had connected over social media after Pat’s diagnosis, and Pete’s large network of friends, athletes, and supporters turned the challenge into a wildfire. Within weeks, it had spread globally. More than 28 million people posted, commented on, or liked an Ice Bucket Challenge video on Facebook alone. On YouTube, tens of thousands of individual challenge videos racked up over 43 million views.

Where the Money Went

The surge in donations was unlike anything the ALS Association had seen. In a three-week stretch from late July to mid-August 2014, the organization received $15.6 million, compared to $1.8 million during the same period the previous year. More than 307,000 first-time donors contributed. By the time the campaign wound down, total donations had exceeded $115 million.

The ALS Association tripled its annual research budget in the years following the challenge. That money funded some of the largest and most consequential ALS research efforts ever undertaken, including massive genome sequencing projects and clinical drug trials.

Gene Discoveries and New Treatments

One of the most significant outcomes was the discovery of new genes linked to ALS. Researchers funded by Ice Bucket Challenge donations identified variations in a gene called NEK1, which plays multiple roles in neuron function. Those variations appear in roughly 3 percent of all ALS cases, both inherited and spontaneous, making it one of the most common genetic contributors to the disease in North America and Europe.

The funding also supported what became the largest genetic study of ALS in history. To identify another gene connected to the disease, KIF5A, researchers compared over 10 million gene variants between more than 20,000 people with ALS and nearly 60,000 control samples. The effort involved over 200 researchers and nine international ALS research groups, a scale of collaboration that would not have been possible without the challenge’s fundraising.

Beyond genetics, Ice Bucket Challenge money helped push a treatment toward approval. The ALS Association invested $2.2 million into the development and clinical trials of a drug called AMX0035, providing early grants that funded a pilot study and a phase 2 trial. The organization also led a years-long advocacy campaign that pressed the FDA to approve the treatment before a larger trial had finished. It became the first ALS treatment directly funded by Ice Bucket Challenge donations to receive FDA approval.

Why It Worked

The challenge hit a rare combination of elements that most awareness campaigns never achieve. It was simple to participate in, visually entertaining, and inherently social. The nomination structure created a chain reaction, with each participant pulling three more people in. It also had a built-in deadline: you had 24 hours to take the challenge or donate, which created urgency.

Critically, it had authentic human stories at its center. Pete Frates, Pat Quinn, and Anthony Senerchia were real people living with a devastating disease, not spokespeople chosen by a marketing team. That authenticity gave the campaign emotional weight that kept it from feeling like just another internet trend. Both Pete Frates and Pat Quinn have since died from ALS, a reminder that the disease the challenge was built around remained deadly even as research accelerated.

For a condition that had long been underfunded and poorly understood by the public, the Ice Bucket Challenge accomplished in one summer what decades of traditional fundraising had not. It made millions of people aware of ALS for the first time and generated the resources to fund genetic breakthroughs and new treatments that are still shaping the fight against the disease today.